We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Peerport Limited (trading as MultiISA) is targeting the multi-million-pound market and claims to offer a holistic approach to Individual Savings Account (ISA) management. The company asserts that traditional ISA managers don’t give users enough flexibility with their investment choices. Current ISA rules restrict investors to only one ISA of each type per tax year. This impedes the investors’ ability to build a diversified IFISA portfolio. Peerport argues that its portal offers investors the freedom to operate multiple accounts like Innovative Finance ISA (IFISA), Cash ISA, and Stocks & Shares ISA under a single ISA management platform. The company will use the investment to finalise the build-out of its end to end platform, fund its office space, manage marketing costs, oversee staffing costs, pay regulatory fees and supervise working capital.

Pitch Rated

88%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £6,033
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £103,672
Hitmarker is a niche jobs website for esports which was launched from Newcastle upon Tyne, England. It has been used by more than 425,000 people over 1.2 m times. In 2019, the company received the "Service Provider of the Year" awarded by UK Esports Awards. It has also won the "Supporting Agency of the Year" finalists at The Esports Awards 2019. Hitmarker also has 2,200+ hiring companies from 54 countries which include HP, Amazon, and Logitech. The company also has a database of 30,000+. The company aims to become the first global hub of esports jobs by gathering all of them in one single location.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £166,050
Get Set Pet (GSP) is a pet supply challenger brand on a mission to build a community of like-minded dog and cat owners that take pride in their relationships with their pets. The company aims to arm pet parents with the information they need to make better nutrition decisions regardless of whether or not they shop with GSP. GSP has acquired over 15,000 customers, generated over 20,000 orders, and delivered £800,000 in total sales. The company has 4.97 out of 5 'Excellent' ratings from over 1,100 verified customer reviews. GSP will use 25% of the investment towards Research and Development (R&D) of its products, 25% on salaries, technology investments and working capital, and 50% on marketing and promotional activities.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £386,375
Pharmafair is an online marketplace for the pharmaceutical supply chain, from the wholesaler to the end consumer. The company estimates that the pharmaceutical market in the UK is worth £43 billion, and it aims to be a major contender in this segment. It plans to use stock exchange trading models to enhance the feel, liquidity and functionality of its application. Its app will also have the ability to list the sale or request purchase of a product and show live news feeds, watchlists, and price alerts in the pharma industry. The company is looking to raise between £75,000 and £100,000 for pre/post-launch marketing and working capital to improve its application further.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £273
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph